Researchers assessed the outcomes of 73 patients with unresectable advanced non-small-cell lung cancer who were treated with 2 different schedules of IMRT: SMART or H-RT.
from Latest articles from Cancer Therapy Advisor News https://ift.tt/2MUPkjw
from Latest articles from Cancer Therapy Advisor News https://ift.tt/2MUPkjw